Skip to main content

and
  1. Article

    Open Access

    Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany – results from the German AFNET registry

    Anticoagulation using vitamin K antagonists (VKAs) significantly reduces the risk of recurrent stroke in stroke patients with atrial fibrillation (AF) and is recommended by guidelines.

    Karl Georg Haeusler, Andrea Gerth, Tobias Limbourg, Ulrich Tebbe in BMC Neurology (2015)

  2. No Access

    Article

    Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort

    Peripheral arterial disease (PAD) and coronary artery disease (CAD) are manifestations of the same underlying condition, atherothrombosis. We compared patients with PAD only with those having PAD and concomita...

    Prof. Dr. med. Uwe Zeymer, Klaus G. Parhofer in Clinical Research in Cardiology (2009)